Business Description
Mankind Pharma Ltd
ISIN : INE634S01028
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.86 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 75.81 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 21.78 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.4 | |||||
3-Year EBITDA Growth Rate | 15.5 | |||||
3-Year EPS without NRI Growth Rate | 13.7 | |||||
3-Year FCF Growth Rate | 28.9 | |||||
3-Year Book Growth Rate | 25.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 19.08 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.57 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.9 | |||||
9-Day RSI | 63.33 | |||||
14-Day RSI | 61.35 | |||||
6-1 Month Momentum % | 17.29 | |||||
12-1 Month Momentum % | 36.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.95 | |||||
Quick Ratio | 2.37 | |||||
Cash Ratio | 1.64 | |||||
Days Inventory | 175.13 | |||||
Days Sales Outstanding | 35.09 | |||||
Days Payable | 137.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.16 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.95 | |||||
Operating Margin % | 21.77 | |||||
Net Margin % | 19.2 | |||||
FCF Margin % | 16.07 | |||||
ROE % | 22.38 | |||||
ROA % | 17.13 | |||||
ROIC % | 25.89 | |||||
ROC (Joel Greenblatt) % | 60.75 | |||||
ROCE % | 26.91 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 53.24 | |||||
Forward PE Ratio | 45.44 | |||||
PE Ratio without NRI | 53.24 | |||||
Price-to-Owner-Earnings | 62.42 | |||||
PS Ratio | 10.22 | |||||
PB Ratio | 10.64 | |||||
Price-to-Tangible-Book | 13.47 | |||||
Price-to-Free-Cash-Flow | 63.58 | |||||
Price-to-Operating-Cash-Flow | 52.29 | |||||
EV-to-EBIT | 44.56 | |||||
EV-to-EBITDA | 38.44 | |||||
EV-to-Revenue | 10.83 | |||||
EV-to-FCF | 57.35 | |||||
Price-to-Graham-Number | 5.84 | |||||
Price-to-Net-Current-Asset-Value | 23.49 | |||||
Price-to-Net-Cash | 89.89 | |||||
Earnings Yield (Greenblatt) % | 2.25 | |||||
FCF Yield % | 1.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mankind Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 110,179.881 | ||
EPS (TTM) (₹) | 52.7 | ||
Beta | 0 | ||
Volatility % | 27.75 | ||
14-Day RSI | 61.35 | ||
14-Day ATR (₹) | 98.661225 | ||
20-Day SMA (₹) | 2645.5575 | ||
12-1 Month Momentum % | 36.4 | ||
52-Week Range (₹) | 1890.05 - 2920.05 | ||
Shares Outstanding (Mil) | 412.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mankind Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mankind Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Mankind Pharma Ltd Frequently Asked Questions
What is Mankind Pharma Ltd(BOM:543904)'s stock price today?
When is next earnings date of Mankind Pharma Ltd(BOM:543904)?
Does Mankind Pharma Ltd(BOM:543904) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |